BioRevolution
- All
- ETF Education
- New Rate Regime
- Quality for Volatility
- India
- Japan
- Artificial Intelligence
- Fixed Income
- Megatrends
- Emerging Markets
- Quality Dividend Growth
- Digital Assets
- Model Portfolios
- BTM Podcast Series
- Advisor Solutions Series
- Women in Asset Management Series
- Index Rebalance Series
- Currency Hedged Equity
At WisdomTree, we work with Dr. Jamie Metzl on a strategy that we term the BioRevolution. Dr. Metzl recently wrote a book, Superconvergence: How the Genetics, Biotech, and AI Revolutions Will Transform our Lives, Work, and World. In this second part of our BioRevolution blog series, Christopher Gannatti summarizes a few key points from the book including the journey to the mRNA vaccine.
Read the article
At WisdomTree, we work with Dr. Jamie Metzl on a strategy that we term the BioRevolution. Dr. Metzl recently wrote a book, Superconvergence: How the Genetics, Biotech, and AI Revolutions Will Transform our Lives, Work, and World. Christopher Gannatti summarizes a few key points from the book including the potential of the self-driving lab.
Read the article
Bill Gates recently posed five questions about AI and its potential to improve innovation in healthcare in his annual letter. Christopher Gannatti takes a look at each question and then highlights a WisdomTree strategy that focuses on the biotechnology sphere.
Read the article
The technologies of the AI, genetics and biotechnology revolutions tend to overlap, continuously accelerating innovation and impact. These impacts are being seen in many different sectors, including Health Care. Christopher Gannatti highlights an example of how megatrends can collide.
Read the article
Biotech stocks have been underperforming for three years, but could a recent breakthrough in CRISPR therapy change the tide? Christopher Gannatti explores potential opportunities and how to invest.
Read the article
We recently spoke with Jamie Metzl, Founder and Chair of One Shared World, on how the coming decades could be impacted by the BioRevolution. Christopher Gannatti provides a recap of the discussion, which covered aspect of human development and generative artificial intelligence.
Read the article
